The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer

This publication has 32 references indexed in Scilit:

• Identification of signal transduction pathways involved in constitutive NF-κB activation in breast cancer cells
  Oncogene, 2002
• Aberrant rel/nfkb genes and activity in human cancer
  Oncogene, 1999
• The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosis
  Genes & Development, 1999
• NF-κB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1α
  Proceedings of the National Academy of Sciences, 1998
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996
• Structure, Regulation and Function of NF-kappaB
  Annual Review of Cell Biology, 1994
• NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts.
  The Journal of Experimental Medicine, 1992
• Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer
  Cancer Letters, 1992
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
  Histopathology, 1991
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987